Skip to main content
SpringerLink
Log in

Pharmacogenetics of antipsychotic-induced weight gain

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Antipsychotic medications have been associated with considerable weight gain. The degree of inter-individual variability and known genetic contributions to obesity suggest a combination of genetic and environmental factors. In the absence of established mechanisms and valid predictors for this relevant adverse effect, pharmacogenetic studies may provide the basis for the development of individualized treatment and preventive interventions.

Objective

The aim of the present review is to analyze the theoretical and empirical knowledge base for the selection of the most promising target genes that may contribute to antipsychotic-induced weight gain.

Methods

Examination of the preclinical and clinical literature that can inform the rational choice of target genes that may play a role in the development of adverse changes in body composition associated with antipsychotic treatment.

Results

Theoretically, candidate gene selection can be guided by knowledge about molecular pathways associated with obesity, receptors modulated by antipsychotic drugs, and enzymes implicated in their metabolism and bioavailability. While most available data relate to the general mechanisms of obesity and few studies have directly examined the genetic contributions to antipsychotic-induced weight gain, several genes warrant further investigation. These include the 5-HT2C, pro-opiomelanocortin, leptin, ghrelin, tumor necrosis factor alpha, adiponectin, dopamine D2 receptor, histamine-H1 receptor, and alpha1, beta2 and beta3 adrenergic receptor genes.

Conclusions

Pharmacogenetic studies can provide powerful tools for the pre-treatment identification of individuals at high risk for antipsychotic-induced weight gain, to uncover biological mechanisms that may even generalize to non-drug-induced weight gain, and to isolate novel targets for treatments of weight gain and obesity. To enhance power, future studies should pay close attention to population selection and avoidance/control of confounds, particularly past treatment exposure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale MC, Hayakawa K (1996) The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord 20:501–506

    CAS  PubMed  Google Scholar 

  • Allison DB, Heo M, Faith MS, Pietrobelli A (1998) Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 22:559–566

    Article  CAS  PubMed  Google Scholar 

  • Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686–1696

    CAS  PubMed  Google Scholar 

  • Allison DB, Mackell JA, McDonnell DD (2003) The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv 54:565–567

    Article  PubMed  Google Scholar 

  • Alvarez GE, Beske SD, Ballard TP, Davy KP (2002) Sympathetic neural activation in visceral obesity. Circulation 106:2533–2536

    Article  PubMed  Google Scholar 

  • American Diabetes Association (2001) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 24:S5–S20

    Google Scholar 

  • Arner P, Hoffstedt J (1999) Adrenoceptor genes in human obesity. J Intern Med 245:667–672

    Article  CAS  PubMed  Google Scholar 

  • Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120:337–345

    CAS  PubMed  Google Scholar 

  • van Baak MA (2001) The peripheral sympathetic nervous system in human obesity. Obes Rev 2:3–14

    Article  PubMed  Google Scholar 

  • Bacanu SA, Devlin B, Roeder K (2002) Association studies for quantitative traits in structured populations. Genet Epidemiol 22:78–93

    Article  PubMed  Google Scholar 

  • Baptista T (1999) Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 100:3–16

    CAS  PubMed  Google Scholar 

  • Basile VS, Masellis M, Potkin SG, Kennedy JL (2002a) Pharmacogenomics in schizophrenia: the quest for individualized therapy. Hum Mol Genet 11:2517–2530

    Article  CAS  PubMed  Google Scholar 

  • Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL (2002b) 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 360:1790–1791

    Article  Google Scholar 

  • Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL (2001) Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 23:45–66

    Google Scholar 

  • Berridge KC (1996) Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20:1–25

    Article  CAS  PubMed  Google Scholar 

  • Bina KG, Cincotta AH (2000) Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 71:68–78

    Article  CAS  PubMed  Google Scholar 

  • Bjorntorp P, Rosmond R (2000) Obesity and cortisol. Nutrition 16:924–936

    Article  CAS  PubMed  Google Scholar 

  • Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, Distler A, Sharma AM (2001) Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 25:581–585

    Article  CAS  PubMed  Google Scholar 

  • Brichard SM, Delporte ML, Lambert M (2003) Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res 35:337–342

    Article  CAS  PubMed  Google Scholar 

  • Buckley PF (2001) Broad therapeutic uses of atypical antipsychotic medications. Biol Psychiatry 50:912–924

    Article  CAS  PubMed  Google Scholar 

  • Buemann B, Vohl MC, Chagnon M, Chagnon YC, Gagnon J, Perusse L, Dionne F, Despres JP, Tremblay A, Nadeau A, Bouchard C (1997) Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 5:186–192

    CAS  PubMed  Google Scholar 

  • Bugajski J, Janusz Z (1981) Lipolytic responses induced by intracerebroventricular administration of histamine in the rat. Agents Actions 11:147–150

    CAS  PubMed  Google Scholar 

  • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  • Casey DE, Zorn SH (2001) The pharmacology of weight gain with antipsychotics. J Clin Psychiatry 7:4–10

    Google Scholar 

  • Chagnon YC, Rankinen T, Snyder EE, Weisnagel SJ, Perusse L, Bouchard C (2003) The human obesity gene map: the 2002 update. Obes Res 11:313–367

    CAS  PubMed  Google Scholar 

  • Chu NF, Chang JB, Shieh SM (2003) Plasma leptin, fatty acids, and tumor necrosis factor-receptor and insulin resistance in children. Obes Res 11:532–540

    CAS  PubMed  Google Scholar 

  • Clement K, Ruiz J, Cassard-Doulcier AM, Bouillaud F, Ricquier D, Basdevant A, Guy-Grand B, Froguel P (1996) Additive effect of A→G (−3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 20:1062–1066

    CAS  PubMed  Google Scholar 

  • Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guygrand B (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398–401

    Article  CAS  PubMed  Google Scholar 

  • Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R (1993) The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol 50:76–85

    Google Scholar 

  • Commuzzie AG, Allison DB (1998) The search for human obesity genes. Science 280:1374–1377

    Article  PubMed  Google Scholar 

  • Comuzzie AG, Blangero J, Mahaney MC, Mitchell BD, Hixson JE, Samollow PB, Stern MP, MacCluer JW (1995) Major gene with sex-specific effects influences fat mass in Mexican Americans. Genet Epidemiol 12:475–488

    CAS  PubMed  Google Scholar 

  • Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stern MP, MacCluer JW, Blangero J (1997) A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 15:273–276

    CAS  PubMed  Google Scholar 

  • Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AE, Maas D, Takahashi M, Kihara S, Tanaka S, Matsuzawa Y, Blangero J, Cohen D, Kissebah A (2001) The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86:4321–4325

    Article  CAS  PubMed  Google Scholar 

  • Correll CU, Leucht S, Kane JM (2004) Reduced risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of one-year studies. Am J Psychiatry 161:1–12

    Article  Google Scholar 

  • Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630

    Article  PubMed  Google Scholar 

  • Dahl ML (2002) Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing? Clin Pharmacokinet 41:453–470

    CAS  PubMed  Google Scholar 

  • Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID (2002) Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 10:401–407

    CAS  PubMed  Google Scholar 

  • De Vos P, Saladin R, Auwerx J, Staels B (1995) Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 270:15958–15961

    Article  PubMed  Google Scholar 

  • Del Giudice M, CirilloG, Santoro N, D’Urso L, Carbone MT, Di Toro R, Perrone L (2001) Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord 25:61–67

    Article  Google Scholar 

  • Dietz WH (1998) Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 101:518–525

    CAS  PubMed  Google Scholar 

  • Dobson MG, Redfern CP, Unwin N, Weaver JU (2001) The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab 86:2270–2274

    Article  CAS  PubMed  Google Scholar 

  • Endo K, Yanagi H, Hirano C, Hamaguchi H, Tsuchiya S, Tomura S (2000) Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord 24:443–449

    Article  CAS  PubMed  Google Scholar 

  • Epstein LH, Jaroni JL, Paluch RA, Leddy JJ, Vahue HE, Hawk L, Wileyto EP, Shields PG, Lerman C (2002) Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes Res 10:1232–1240

    PubMed  Google Scholar 

  • Feng N, Adler-Wailes D, Elberg J, Chin J, Fallon E, Carr A, Frazer T, Yanovski J (2003) Sequence variants of the POMC gene and their associations with body composition in children. Obes Res 11:619–624

    CAS  PubMed  Google Scholar 

  • Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, Richart C, Soler J (1997) The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46:1468–1472

    CAS  PubMed  Google Scholar 

  • Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH (2002) In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. J Pharmacol Exp Ther 301:229–233

    Article  CAS  PubMed  Google Scholar 

  • Floris M, Lejeune J, Deberdt W (2001) Effect of amantadine on weight gain during olanzapine treatment. Eur Neuropsychopharmacol 11:181–182

    Article  CAS  PubMed  Google Scholar 

  • Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T (1998) Meta-analysis of the association of Trp64Arg polymorphism of beta3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 83:2441–2444

    Article  CAS  PubMed  Google Scholar 

  • Ghaeli P, Dufresne RL (1999) Elevated serum triglycerides with clozapine resolved with risperidone in four patients. Pharmacotherapy 19:1099–1101

    Article  CAS  PubMed  Google Scholar 

  • Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A, Pollmacher T (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33:407–418

    Article  CAS  PubMed  Google Scholar 

  • Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, Vaillant E, Lorentz N, Basdevant A, Clement K, Guy-Grand B, Froguel P (1998) A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 20:304–308

    Article  CAS  PubMed  Google Scholar 

  • Hautanen A, Adlercreutz H (1993) Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med 234:461–469

    CAS  PubMed  Google Scholar 

  • Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC (2000) Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 157:975–981

    Article  CAS  PubMed  Google Scholar 

  • Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F (1998) Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 28:59–66

    Article  CAS  PubMed  Google Scholar 

  • Hinze-Selch D, Schuld A, Kraus T, Kuhn M, Uhr M, Haack M, Pollmacher T (2000) Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 23:13–19

    Article  CAS  PubMed  Google Scholar 

  • Hixson JE, Almasy L, Cole S, Birnbaum S, Mitchell BD, Mahaney MC, Stern MP, MacCluer JW, Blangero J, Comuzzie AG (1999) Normal variation in leptin levels is associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 84:3187–3191

    Article  CAS  PubMed  Google Scholar 

  • Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P (2000) Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 43:117–120

    Article  CAS  PubMed  Google Scholar 

  • Hoffstedt J, Eriksson P, Mottaui-Tabar S, Arner P (2002) A polymorphism in the leptin promotor region (−2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 34:355–359

    Article  CAS  PubMed  Google Scholar 

  • Hong CJ, Lin CH, Yu YW, Chang SC, Wang SY, Tsai SJ (2002) Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment. Psychiatr Genet 12:169–171

    Article  PubMed  Google Scholar 

  • Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409–2415

    CAS  PubMed  Google Scholar 

  • Ingram DK (2000) Age-related decline in physical activity: generalization to nonhumans. Med Sci Sports Exerc 32:1623–1629

    Article  CAS  PubMed  Google Scholar 

  • Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K (1999) Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42:98–101

    Article  CAS  PubMed  Google Scholar 

  • Kamizono S, Yamada K, Seki N, Higuchi T, Kimura A, Nonaka K, Itoh K (2000) Susceptible locus for obese type 2 diabetes mellitus in the 5′-flanking region of the tumor necrosis factor-alpha gene. Tissue Antigens 55:449–452

    Article  CAS  PubMed  Google Scholar 

  • Kane JM (2001) Extrapyramidal side effects are unacceptable. Eur Neuropsychopharmacol 11:S397–S403

    Article  CAS  PubMed  Google Scholar 

  • Kawachi I (1999) Physical and psychological consequences of weight gain. J Clin Psychiatry 60(Suppl 21):5–9

    Google Scholar 

  • Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111–2119

    CAS  PubMed  Google Scholar 

  • Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG (2000) Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 97:14478–14483

    Article  CAS  PubMed  Google Scholar 

  • Korbonits M, Gueorguiev M, O’Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB, Froguel P (2002) A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 87:4005–4008

    Article  CAS  PubMed  Google Scholar 

  • Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL (2003) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28:519–526

    Article  CAS  PubMed  Google Scholar 

  • Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155–157

    Article  CAS  PubMed  Google Scholar 

  • Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M (2003) Finnish Diabetes Prevention Study. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52:1872–1876

    CAS  PubMed  Google Scholar 

  • Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W et al. (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921

    Article  PubMed  Google Scholar 

  • Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 100:3005–3013

    CAS  PubMed  Google Scholar 

  • Lee JH, Reed DR, Price RA (1997) Familial risk ratios for extreme obesity: implications for mapping human obesity genes. Int J Obes Relat Metab Disord 21:935–940

    Article  CAS  PubMed  Google Scholar 

  • Li WD, Reed DR, Lee JH, Xu W, Kilker RL, Sodam BR, Price RA (1999) Sequence variants in the 5′ flanking region of the leptin gene are associated with obesity in women. Ann Hum Genet 63:227–234

    Article  PubMed  Google Scholar 

  • Liebzeit KA, Markowitz JS, Caley CF (2001) New onset diabetes and atypical antipsychotics. Eur Neuropsychopharmacol 11:25–32

    Article  CAS  PubMed  Google Scholar 

  • Malhotra AK (2001) Pharmacogenomics and schizophrenia: clinical implications. Pharmacogenomics J 1:109–114

    CAS  Google Scholar 

  • Malhotra AK, Goldman D (1999) Benefits and pitfalls encountered in psychiatric genetic association studies. Biol Psychiatry 45:544–550

    Article  CAS  PubMed  Google Scholar 

  • Malhotra AK, Murphy GM, Kennedy JL (2004) Pharmacogenetics of psychotropic drugs. Am J Psychiatry 161:780–796

    Article  PubMed  Google Scholar 

  • Mammes O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, Colas-Linhart N, Fumeron F (1998) Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes 47:487–489

    CAS  PubMed  Google Scholar 

  • Mancama D, Arranz MJ, Munro J, Makoff A, Kerwin R (2000) The histamine 1 and 2 receptors genes—candidates for schizophrenia and clozapine drug response. GeneScreen 1:29–34

    Article  CAS  Google Scholar 

  • Mancama D, Arranz MJ, Munro J, Osborne S, Makoff A, Collier D, Kerwin R (2002) Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci Lett 333:207–211

    Article  CAS  PubMed  Google Scholar 

  • Martel P, Fantino M (1996) Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. Pharmacol Biochem Behav 53:221–226

    Article  CAS  PubMed  Google Scholar 

  • Martinez JA, Corbalan MS, Sanchez-Villegas A, Forga L, Marti A, Martinez-Gonzalez MA (2003) Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J Nutr 133:2549–2554

    CAS  PubMed  Google Scholar 

  • Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T (2001a) Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes 50:385–391

    CAS  PubMed  Google Scholar 

  • Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T (2001b) Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice. Diabetes 50:376–384

    CAS  PubMed  Google Scholar 

  • McIntyre RS, McCann SM, Kennedy SH (2001) Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 46:273–281

    CAS  PubMed  Google Scholar 

  • Meirhaeghe A, Helbecque N, Cottel D, Amouyel P (1999) Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 353:896

    Article  CAS  PubMed  Google Scholar 

  • Melkersson KI, Hulting AL, Brismar KE (2000) Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 61:742–749

    CAS  PubMed  Google Scholar 

  • Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V, Doria A (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306–2312

    CAS  PubMed  Google Scholar 

  • Mir S, Taylor D (2001) Atypical antipsychotics and hyperglycaemia. Int Clin Psychopharmacol 16:63–73

    Article  CAS  PubMed  Google Scholar 

  • Montague CT, Faroogi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O’Rahilly S (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903–907

    Article  CAS  PubMed  Google Scholar 

  • Monteleone P, Fabrazzo M, Tortorella A, La Pia S, Maj M (2002) Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment. J Clin Psychopharmacol 22:424–426

    Article  CAS  PubMed  Google Scholar 

  • Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194–198

    Article  CAS  PubMed  Google Scholar 

  • National Task Force on the Prevention and Treatment of Obesity (2000) Overweight, obesity, and health risk. Arch Intern Med 160:898–904

    Article  PubMed  Google Scholar 

  • Norman RA, Bogardus C, Ravussin E (1995) Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. J Clin Invest 96:158–162

    CAS  PubMed  Google Scholar 

  • Oizumi T, Daimon M, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Igarashi M, Eguchi H, Manaka H, Tominaga M, Kato T (2001) Funagata Diabetes Study. Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 24:1579–1583

    CAS  PubMed  Google Scholar 

  • Parkinson WL, Weingarten HP (1990) Dissociative analysis of ventromedial hypothalamic obesity syndrome. Am J Physiol 259:R829–R835

    CAS  PubMed  Google Scholar 

  • Paterson AD (1997) Case-control association studies in complex traits—the end of an era? Mol Psychiatry 2:277–228

    Article  CAS  PubMed  Google Scholar 

  • Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, Cowley AW, Hamet P (2000) Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 36:14–19

    CAS  PubMed  Google Scholar 

  • Pereira AC, Floriano MS, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE (2003) Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 42:685–692 (Epub 2003 Aug 04)

    Article  CAS  PubMed  Google Scholar 

  • Perez C, Palou A, Serrano Rios M (2003) The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol (Oxf) 59:476–481

    Google Scholar 

  • Perkins DO (1999) Adherence to antipsychotic medications. J Clin Psychiatry 60:25–30

    Google Scholar 

  • Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM, Rosenbaum JF, Fava M (2003) Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 54:879–883

    Article  CAS  PubMed  Google Scholar 

  • Pihlajamaki J, Ylinen M, Karhapaa P, Vauhkonen I, Laakso M (2003) The effect of the −308A allele of the TNF-alpha gene on insulin action is dependent on obesity. Obes Res 11:912–917

    CAS  PubMed  Google Scholar 

  • Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Oliver M, Pesich R, Herbert J, Chen YD, Dzau VJ, Curb D, Olshen R, Risch N, Cox DR, Botstein D (2001) High-throughput genotyping with single nucleotide polymorphisms. Genom Res 11:1262–1268

    CAS  Google Scholar 

  • Reynolds GP, Zhang ZJ, Zhang XB (2002) Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359:2086–2087

    Article  CAS  PubMed  Google Scholar 

  • Reynolds GP, Zhang Z, Zhang X (2003) Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am J Psychiatry 160:677–679

    Article  PubMed  Google Scholar 

  • Risch N, Teng J (1998) The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res 8:1273–1288

    CAS  PubMed  Google Scholar 

  • Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA (1999) Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 156:544–549

    CAS  PubMed  Google Scholar 

  • Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL (2002) Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 8:2391–2394

    Article  Google Scholar 

  • Rosmond R (2002) The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res 10:1078–1086

    CAS  PubMed  Google Scholar 

  • Rotimi CN, Comuzzie AG, Lowe WL, Luke A, Blangero J, Cooper RS (1999) The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes 48:643–644

    CAS  PubMed  Google Scholar 

  • Ryan MC, Thakore JH (2002) Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci 71:239–257

    Article  CAS  PubMed  Google Scholar 

  • Sakata T, Kurokawa M, Oohara A, Yoshimatsu H (1994) A physiological role of brain histamine during energy deficiency. Brain Res Bull 35:135–139

    Article  CAS  PubMed  Google Scholar 

  • Sakata T, Yoshimatsu H, Kurokawa M (1997) Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism. Nutrition 13:403–411

    Article  CAS  PubMed  Google Scholar 

  • Schultz SK, Arndt S, Ho BC, Oliver SE, Andreasen NC (1999) Impaired glucose tolerance and abnormal movements in patients with schizophrenia. Am J Psychiatry 156:640–642

    CAS  PubMed  Google Scholar 

  • Scordo MG, Spina E (2002) Cytochrome P450 polymorphisms and response to antipsychotic therapy. Pharmacogenomics 3:201–218

    CAS  PubMed  Google Scholar 

  • Seeley RJ, Woods SC (2003) Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci 4:901–909

    Article  CAS  PubMed  Google Scholar 

  • Sethi JK, Hotamisligil GS (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10:19–29

    Article  CAS  PubMed  Google Scholar 

  • Shalitin S, Phillip M (2003) Role of obesity and leptin in the pubertal process and pubertal growth—a review. Int J Obes 27:869–874

    Article  CAS  Google Scholar 

  • Shiloah E, Witz S, Abramovitch Y, Cohen O, Buchs A, Ramot Y, Weiss M, Unger A, Rapoport MJ (2003) Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity. Diabetes Care 26:1462–1467

    PubMed  Google Scholar 

  • Simansky KJ (1996) Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73:37–42

    Article  CAS  PubMed  Google Scholar 

  • Snitker S, Macdonald I, Ravussin E, Astrup A (2000) The sympathetic nervous system and obesity: role in aetiology and treatment. Obes Rev 1:5–15

    Article  CAS  PubMed  Google Scholar 

  • Strachan T, Read AP (1996) Mutation and instability of human DNA. Hum Mol Genet 10:241–273

    Google Scholar 

  • Strassnig M, Brar JS, Ganguli R (2003) Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr Res 62:73–76

    Article  PubMed  Google Scholar 

  • Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G, Barbato A, D’Elia L, Trevisan M, Farinaro E (2001) Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 19:399–406

    Article  CAS  PubMed  Google Scholar 

  • Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genetics 18:213–215

    CAS  Google Scholar 

  • Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, Machicao F, Haring H (2002) Association of the T–G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51:37–41

    CAS  PubMed  Google Scholar 

  • Tataranni PA, Baier L, Jenkinson C, Harper I, Del Parigi A, Bogardus C (2001) A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure. Diabetes 50:901–904

    CAS  PubMed  Google Scholar 

  • Taylor DM, McAskill R (2000) Atypical antipsychotics and weight gain—a systematic review. Acta Psychiatr Scand 101:416–432

    Article  CAS  PubMed  Google Scholar 

  • Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374:542–546

    Article  CAS  PubMed  Google Scholar 

  • Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R (2002) Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 26:137–141

    Article  CAS  PubMed  Google Scholar 

  • Thomas GN, Tomlinson B, Chan JC, Young RP, Critchley JA (2000a) The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 24:545–551

    Article  CAS  PubMed  Google Scholar 

  • Thomas GN, Tomlinson B, Critchley JA (2000b) Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension 36:177–182

    CAS  PubMed  Google Scholar 

  • Tsai SJ, Hong CJ, Yu YW, Lin CH (2002) −759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 360:1790

    Article  Google Scholar 

  • Ukkola O, Ravussin E, Jacobson P, Snyder EE, Chagnon M, Sjostrom L, Bouchard C (2001a) Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86:3996–3999

    Article  CAS  PubMed  Google Scholar 

  • Ukkola O, Perusse L, Chagnon YC, Despres JP, Bouchard C (2001b) Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int J Obes Relat Metab Disord 25:1332–1339

    Article  CAS  PubMed  Google Scholar 

  • Ukkola O, Rosmond R, Tremblay A, Bouchard C (2001c) Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis 157:221–224

    Article  CAS  PubMed  Google Scholar 

  • Ukkola O, Tremblay A, Bouchard C (2001d) Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord 25:1604–1608

    Article  CAS  PubMed  Google Scholar 

  • Ukkola O, Ravussin E, Jacobson P, Perusse L, Rankinen T, Tschop M, Heiman ML, Leon AS, Rao DC, Skinner JS, Wilmore JH, Sjostrom L, Bouchard C (2002) Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 10:782–791

    CAS  PubMed  Google Scholar 

  • Ukkola O, Ravussin E, Jacobson P, Sjostrom L, Bouchard C (2003) Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 52:881–884

    Article  CAS  PubMed  Google Scholar 

  • Valve R, Heikkinen S, Rissanen A, Laakso M, Uusitupa M (1998) Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns. Diabetologia 41:357–361

    Article  CAS  PubMed  Google Scholar 

  • Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P (2002) Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607–2614

    Article  CAS  PubMed  Google Scholar 

  • Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P (2000) Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470–1480

    Article  CAS  PubMed  Google Scholar 

  • Weaver JU, Hitman GA, Kopelman PG (1992) An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol 9:295–300

    CAS  PubMed  Google Scholar 

  • Weiden PJ, Mackell JA, McDonnell DD (2004) Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 66:51–57

    Article  PubMed  Google Scholar 

  • Wilmot CA, Sullivan AC, Levin BE (1988) Effects of diet and obesity on brain alpha 1- and alpha 2-noradrenergic receptors in the rat. Brain Res 453:157–166

    Article  CAS  PubMed  Google Scholar 

  • Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, Mintz J, Marder SR (1999) Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 60:358–363

    CAS  PubMed  Google Scholar 

  • Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC (2002) The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 63:856–865

    CAS  PubMed  Google Scholar 

  • Woods SC, Seeley RJ, Porte D, Schwartz MW (1998) Signals that regulate food intake and energy homeostasis. Science 280:1378–1383

    Article  CAS  PubMed  Google Scholar 

  • Woods SC, Clegg DJ (2003) Signals that control central appetite regulation. In: Eiholzer U, l’Allemand D, Zipf WB (eds) Prader-Willi Syndrome as a model for obesity. International Symposium, Zurich, 2002. Karger, Basel, pp 15–30

  • Wybranska I, Malczewska-Malec M, Niedbal S, Naskalski JW, Dembinska-Kiec A (2003) The TNF-alpha gene NcoI polymorphism at position −308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity. Clin Chem Lab Med 41:501–510

    CAS  PubMed  Google Scholar 

  • Yamada K, Ishiyama-Shigemoto S, Ichikawa F, Yuan X, Koyanagi A, Koyama W, Nonaka K (1999) Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 84:1754–1757

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7:941–946

    Google Scholar 

  • Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M, Sakata T (1999) Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes 48:2286–2291

    CAS  PubMed  Google Scholar 

  • Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K (2000) Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia 43:373–376

    Article  CAS  PubMed  Google Scholar 

  • Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmacher T (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37:193–220

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by NIH grant MH01760 (AKM), a NARSAD Independent Investigator Award (A.K.M.), and the Stanley Medical Research Institute (A.K.M.) and the Zucker Hillside Hospital Intervention Research Center for Schizophrenia grant 5P30MH60575 from the National Institute of Mental Health, Bethesda, Md., USA.

Author information

Authors and Affiliations

  1. Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore–Long Island Jewish Health System, Glen Oaks, NY 11004, USA

    Christoph U. Correll & Anil K. Malhotra

  2. Albert Einstein College of Medicine, Bronx, N.Y., USA

    Anil K. Malhotra

Authors
  1. Christoph U. Correll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anil K. Malhotra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anil K. Malhotra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Correll, C.U., Malhotra, A.K. Pharmacogenetics of antipsychotic-induced weight gain. Psychopharmacology 174, 477–489 (2004). https://doi.org/10.1007/s00213-004-1949-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-1949-9

Keywords

Search

Navigation